ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

Fewer Young Scientists win NIH Grants, Study

September 30, 1994

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000

Kennedy Bill Would Extend Cancer Program Three Years, Kill Budget Bypass

May 4, 1979

Oncology Nursing Society Installs Officers, Offers Virtual Congress Online For Credit.

June 15, 2001

Larynx Preservation Provides Better Voice Quality For Patients

February 29, 2008